Skip to content
Study details
Enrolling now

A Study of Pulmonary Hypertension Peripheral Limitations

Mayo Clinic
NCT IDNCT05968859ClinicalTrials.gov data as of Apr 2026
Target enrollment

45

Study length

about 4.2 years

Ages

18+

Locations

1 site in MN

What this study is about

Researchers are testing whether aerobic training or leg training improves symptoms and quality of life in people with pulmonary arterial hypertension (PAH). The trial will last for 1550 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Aerobic Training
  • 2.Participate in Leg Training

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Change in Quality of Life as measured by the 36-Item Short-Form Survey (SF-36), Change in Quality of Life as measured by the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire, Change in Quality of Life as measured by the emPHasis-10 questionnaire

Body systems

Respiratory